| Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections (NCT04722029) | Nationwide Children's Hospital | 2021-10-01 |
| A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD (NCT04993755) | Transposon Therapeutics, Inc. | 2021-10-01 |
| Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma (NCT05047991) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-10-01 |
| Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer (NCT05266820) | Fujian Cancer Hospital | 2021-10-01 |
| Hydroxychloroquine and Indapamide in SPMS (NCT05013463) | University of Calgary | 2021-10-01 |
| Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness (NCT05846906) | Beni-Suef University | 2021-10-01 |
| TCA Peel and Photobiomodulation for Hand Rejuvenation (NCT04485091) | University of Nove de Julho | 2021-10-01 |
| Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis (NCT05058417) | Sadat City University | 2021-10-01 |
| A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer (NCT05016973) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-10-01 |
| Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome (NCT04960618) | Memorial Sloan Kettering Cancer Center | 2021-10-01 |
| Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia (NCT05024877) | Peking Union Medical College Hospital | 2021-10-01 |
| Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer (NCT04592211) | Yonsei University | 2021-10-01 |
| Treatment of Persistent Pulmonary Hypertension in Neonates With Nebulized Magnesium Sulfate (NCT06603766) | Benha University | 2021-10-01 |
| Trial of Ondansetron as a Parkinson's HAllucinations Treatment (NCT04167813) | University College, London | 2021-10-01 |
| Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients (NCT05424315) | Omar Younis | 2021-10-01 |
| TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN) (NCT04760431) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-10-01 |
| Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes (NCT03885245) | University of Colorado, Denver | 2021-10-01 |
| Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill (NCT05243186) | Ariel University | 2021-10-01 |
| Effects of Masticatory Muscles Training Exercises on the Masticatory Performance and Rehabilitation of Stroke Patients (NCT05503420) | The University of Hong Kong | 2021-10-01 |
| A Novel E-health Platform (NCT05024903) | Daren K. Heyland | 2021-10-01 |
| Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines (NCT05067946) | Genexine, Inc. | 2021-10-01 |
| Microtransplantation for Ovarian Cancer (NCT05095558) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2021-10-01 |
| Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy (NCT05097248) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-10-01 |
| Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities (NCT04982900) | Ruijin Hospital | 2021-10-01 |
| MR-linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor (NCT05163509) | Sun Yat-sen University | 2021-10-01 |
| ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas (NCT05079022) | Peking University People's Hospital | 2021-10-01 |
| Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19 (NCT04278963) | China Academy of Chinese Medical Sciences | 2021-10-01 |
| Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma (NCT05070403) | H. Lee Moffitt Cancer Center and Research Institute | 2021-10-01 |
| FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients (NCT05020483) | Mayo Clinic | 2021-10-01 |
| Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma (NCT05048017) | Peking Union Medical College Hospital | 2021-10-01 |
| Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 (NCT05054075) | Universidade do Porto | 2021-10-01 |
| A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes (NCT05063253) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2021-10-01 |
| Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial (NCT05035238) | Health Institutes of Turkey | 2021-10-01 |
| Study of Magrolimab in Patients With Solid Tumors (NCT04827576) | Gilead Sciences | 2021-10-01 |
| A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma (NCT04533490) | The First Affiliated Hospital of Zhengzhou University | 2021-10-01 |
| SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial (NCT04802408) | Milton S. Hershey Medical Center | 2021-10-01 |
| Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies (NCT04994626) | Chinese Academy of Medical Sciences | 2021-10-01 |
| PSMA-PET to Guide Prostatectomy (NCT05381103) | Five Eleven Pharma, Inc. | 2021-10-01 |
| TTI-0102 for Veterans With TBI (NCT04262895) | VA Office of Research and Development | 2021-10-01 |
| ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer (NCT04975451) | Anqin Zhang | 2021-10-01 |
| Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation (NCT05054478) | Assistance Publique - Hôpitaux de Paris | 2021-10-01 |
| Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis (NCT04767698) | Johns Hopkins University | 2021-10-01 |
| ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL (NCT05290090) | Zhejiang Cancer Hospital | 2021-10-01 |
| TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic (NCT04780152) | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 2021-10-01 |
| HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction (NCT05095467) | Xuefei.Wang | 2021-10-01 |
| Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease (NCT05305833) | TC Erciyes University | 2021-10-01 |
| SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma (NCT04948788) | Jiangsu HengRui Medicine Co., Ltd. | 2021-10-01 |
| Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer (NCT05160727) | Zhejiang Cancer Hospital | 2021-10-01 |
| Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC (NCT05125055) | Shanghai Jiao Tong University School of Medicine | 2021-10-01 |
| Phase IIB Study of Recombinant Novel Coronavirus Vaccine (NCT05293223) | Fundación Huésped | 2021-10-01 |
| Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy (NCT04779957) | University Hospital, Toulouse | 2021-10-01 |
| Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis (NCT04841512) | Xalud Therapeutics, Inc. | 2021-10-01 |
| Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars (NCT02968459) | Maternal and Child Health Hospital of Foshan | 2021-10-01 |
| Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations (NCT05222165) | Helsinn Healthcare SA | 2021-10-01 |
| Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer (NCT05019690) | Fujian Cancer Hospital | 2021-10-01 |
| The Efficacy of Probiotic Compared With Placebo Commitment Therapy for Treatment of Major Depressive Disorder (NCT05315401) | Min-Tze LIONG | 2021-10-01 |
| Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric Study (NCT04734691) | Sleiman Marwan-Julien | 2021-10-01 |
| A Single Arm Study of Traditional Chinese Medicine for Plasma Cell Mastitis (NCT05530226) | Shengjing Hospital | 2021-10-01 |
| Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL (NCT05149170) | Chinese Academy of Medical Sciences | 2021-10-01 |
| Centrally Acting ACE Inhibition in SLE (NCT04486118) | Northwell Health | 2021-10-01 |
| Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia (NCT05018936) | Peking Union Medical College Hospital | 2021-10-01 |
| A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries (NCT04893863) | University of Manitoba | 2021-10-01 |
| Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds (NCT04273997) | S.L.A. Pharma AG | 2021-10-01 |
| Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows (NCT04817527) | First Affiliated Hospital Xi'an Jiaotong University | 2021-10-01 |
| CAV Regimen Bridging to HSCT for R/R AL (NCT05190549) | The First Affiliated Hospital of Soochow University | 2021-10-01 |
| A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer (NCT05033132) | Agenus Inc. | 2021-10-01 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections (NCT05030324) | Valenta Pharm JSC | 2021-10-01 |
| Effect of Application Time of 38% Silver Diamine Fluoride Solution on Arresting Dental Caries in Preschool Childre (NCT04655430) | The University of Hong Kong | 2021-10-01 |
| Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction (NCT04063345) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-10-01 |
| Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata (NCT03532958) | Equillium | 2021-10-01 |
| Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease (NCT04974099) | Children's Hospital Medical Center, Cincinnati | 2021-10-01 |
| Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer (NCT04989725) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-10-01 |
| Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer (NCT04891185) | Universitaire Ziekenhuizen KU Leuven | 2021-10-01 |
| Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) (NCT05041907) | University of Oxford | 2021-09-30 |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma (NCT05036681) | M.D. Anderson Cancer Center | 2021-09-30 |
| Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis (NCT05100225) | Bioventus LLC | 2021-09-30 |
| A Study of OLR in First-line Treatment of Mantle Cell Lymphoma (NCT05076097) | Tianjin Medical University Cancer Institute and Hospital | 2021-09-30 |
| A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension (NCT04880031) | GlaxoSmithKline | 2021-09-30 |
| 177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma (NCT04167618) | Y-mAbs Therapeutics | 2021-09-30 |
| A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC) (NCT04965090) | Memorial Sloan Kettering Cancer Center | 2021-09-30 |
| Olinvacimab With Pembrolizumab in Patients With mTNBC (NCT04986852) | PharmAbcine | 2021-09-30 |
| Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients (NCT04338126) | University of Alabama at Birmingham | 2021-09-30 |
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System (NCT04743310) | John Yu | 2021-09-30 |
| Safety of UC-MSC Transfusion for ACLF Patients (NCT04822922) | Hai Li | 2021-09-30 |
| Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes (NCT05035368) | Dompé Farmaceutici S.p.A | 2021-09-30 |
| HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (NCT04904588) | Center for International Blood and Marrow Transplant Research | 2021-09-30 |
| COVID-19 Vaccine Boosters in Patients With CKD (NCT05022329) | Sunnybrook Health Sciences Centre | 2021-09-30 |
| A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer (NCT05044988) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-09-30 |
| Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 (NCT04964414) | Amanda Stapleton | 2021-09-30 |
| Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAML (NCT05513131) | The First Affiliated Hospital with Nanjing Medical University | 2021-09-30 |
| Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer (NCT05435274) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-09-30 |
| Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting (NCT05010460) | Peking Union Medical College Hospital | 2021-09-30 |
| Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine. (NCT04990466) | NeuroRx, Inc. | 2021-09-30 |
| Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis (NCT05054140) | Immunic AG | 2021-09-30 |
| Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis (NCT05048056) | Akesobio Australia Pty Ltd | 2021-09-30 |
| Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma (NCT05018299) | Oneness Biotech Co., Ltd. | 2021-09-30 |
| Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF. (NCT04866056) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2021-09-30 |
| Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract (NCT04617756) | Centre Hospitalier Universitaire de Nīmes | 2021-09-29 |
| Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer (NCT04908813) | Shanghai Henlius Biotech | 2021-09-29 |
| A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities (NCT05051579) | Eli Lilly and Company | 2021-09-29 |